While their study did not assess associations between the allele and clinical symptoms of BD7, their findings and our present results suggest that the enhanced UBAC2 expression associated with these homozygous risk alleles could induce overactivation of the ubiquitination-related pathway, resulting in the development of ocular and CNS lesions or of BD itself. The gene discussed is UBAC2; the disease is Behcet disease.